Form:	(EXPIRED) Canary: PASS Prostatectomy v2.0

CDE ID	CDE Description
* 421	EDRN Participant ID (Go To: 423)
* 423	EDRN Protocol ID (Go To: 422)
* 422	EDRN Site ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 774)
* 774	Date of surgery (MM/DD/YYYY): (Go To: 839)
* 839	ID number of local pathology report: (Go To: 2605)
* 2605	Surgery type: (Go To: 2607)
	Permissible Values (value): Laprascopic/Robotic (1)
	Open (2)
	Other, specify: (97) (Go To: 2606)
* 2606	Surgery type (Other, specify): (Go To: 2607)
* 2607	Nerve-sparing surgery? (Go To: 2608)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown/refused (9)
* 2608	Prostate weight (g): (Go To: 2609)
* 2609	Seminal vesicles attached? (Go To: 4596)
	Permissible Values (value): No (0)
	Yes, both (1)
	Yes, right only (2)
	Yes, left only (3)
4596	ISUP prostate histopathologic grade: (Go To: 1589)
	Permissible Values (value): Grade Group 1 (1)
	Grade Group 2 (2)
	Grade Group 3 (3)
	Grade Group 4 (4)
	Grade Group 5 (5)
	Not applicable (98)
* 1589	Primary Gleason grade: (Go To: 1590)
* 1590	Secondary Gleason grade: (Go To: 1696)
1696	Tertiary Gleason Pattern: (Go To: 1697)
* 1697	Overall Gleason Score: (Go To: 2610)
* 2610	Prostate T-Stage, Pathologic: (Go To: 2611)
	Permissible Values (value): pT0 (2)
	pT2 (13)
	pT2a (14)
	pT2b (15)
	pT2c (27)
	pT3a (30)
	pT3b (31)
	pT4 (34)
* 2611	Prostate N-Stage, Pathologic: (Go To: 2612)
	Permissible Values (value): pNX (1)
	pN0 (2)
	pN1 (7)
* 2612	Prostate M-Stage, Pathologic: (Go To: 1687)
	Permissible Values (value): MX (1)
	M0 (2)
	M1 (3)
	M1a (4)
	M1b (5)
	M1c (6)
* 1687	Total number of lymph nodes examined : (Go To: 2613)
* 2613	Number of lymph nodes with cancer: (Go To: 2614)
* 2614	Estimated tumor volume (cc): (Go To: 2615)
2615	Tumor volume determination method: (Go To: 2617)
	Permissible Values (value): Nickel method (1)
	Volume calculation by mass (2)
	Percent by eye (3)
	Greatest linear dimension (4)
	Other, specify: (97) (Go To: 2616)
	Unknown (99)
2616	Tumor volume determination method (Other, specify): (Go To: 2617)
* 2617	Tumor position: (Go To: 1591)
	Permissible Values (value): Anterior right (1)
	Anterior left (2)
	Posterior right (3)
	Posterior left (4)
	Prostatic apex (5)
	Bladder neck (6)
	Peripheral right (7)
	Peripheral left (8)
	Transition right (9)
	Transition left (10)
	Other, specify: (97) (Go To: 3359)
	Unknown (99)
* 3359	Tumor position: (Other, specify) (Go To: 1591)
* 1591	Perineural invasion: (Go To: 2618)
	Permissible Values (value): Present (1)
	Absent (2)
	Unknown (99)
* 2618	Margin status (presence of cancer at margin): (Go To: 2626)
	Permissible Values (value): Positive (1) (Go To: 2619)
	Negative (2)
	Uncertain (borderline case) (3)
	Unknown/refused (9)
* 2619	Site(s) of positive margin(s): (Go To: 2620)
	Permissible Values (value): Anterior right (1)
	Anterior left (2)
	Posterior right (3)
	Posterior left (4)
	Other, specify: (97) (Go To: 3358)
	Unknown (99)
* 3358	Site of positive margins: (Other, specify) (Go To: 2620)
* 2620	Combined length of positive margin(s) (mm): (Go To: 2626)
* 2626	Extraprostatic extension (EPE) status: (Go To: 2628)
	Permissible Values (value): Positive (1) (Go To: 2627)
	Negative (2)
	Uncertain (borderline case) (3)
	Unknown (99)
* 2627	Extraprostatic extension (EPE) site(s): (Go To: 2628)
	Permissible Values (value): Anterior right (1)
	Anterior left (2)
	Posterior right (3)
	Posterior left (4)
* 2628	Seminal vesicle invasion? (Go To: 2630)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 2629)
	Unknown/refused (9)
* 2629	Seminal vesicle invasion site: (Go To: 2630)
	Permissible Values (value): Right (1)
	Left (2)
	Both (3)
	Unknown (99)
2630	Percent of tumor tissue with Gleason grade greater than 3: (Go To: 1097)
1097	Comments (do not include any participant identifiers) (Go To: End of Form)